Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD
ABSTRACT Objective: To evaluate the value of soluble urokinase-type plasminogen activator receptor (suPAR) in the diagnosis of acute exacerbation of COPD (AECOPD) and in monitoring treatment response, analyzing the relationship between suPAR and fibrinogen in AECOPD. AECOPD leads to increased airwa...
Main Authors: | Gehan Hassan AboEl-Magd, Maaly Mohamed Mabrouk |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Pneumologia e Tisiologia
|
Series: | Jornal Brasileiro de Pneumologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132018000100036&lng=en&tlng=en |
Similar Items
-
Treatment of COPD exacerbations: antibiotics
by: R. Wilson
Published: (2005-09-01) -
The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients
by: Song Q, et al.
Published: (2021-05-01) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01) -
Effectiveness of Telemonitoring for Reducing Exacerbation Occurrence in COPD Patients With Past Exacerbation History: A Systematic Review and Meta-Analysis
by: Jing-wen Lu, et al.
Published: (2021-09-01) -
Emergency department antibiotic use for exacerbations of COPD
by: Tichter AM, et al.
Published: (2018-12-01)